{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:22:40Z","timestamp":1793726560052,"version":"4.6.1"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02157-5","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T19:05:01Z","timestamp":1776020701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ibero-American position statement on therapeutic recommendations for the preventive management of cardiovascular complications in latin-American patients with type 2 diabetes mellitus: consensus of the prevention council of the inter-American society of cardiology (SIAC-PREVENT)"],"prefix":"10.1186","volume":"18","author":[{"given":"Fernando","family":"Wyss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Ullauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joffre Lara","family":"Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Arteaga-Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"G\u00f3mez-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Lopez-Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Armando","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra","family":"Ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Piskorz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Gabriel","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Puente-Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry las","family":"de Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osiris","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Pe\u00f1aherrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Camafort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa F.","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Lituma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1xima","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla Garay","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ponte-Negretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Munera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Lopez \u2013 Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mildren","family":"del Sueldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yedid","family":"Valc\u00e1rcel-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Ortiz \u2013 Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"issue":"2","key":"2157_CR1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.pcd.2020.10.001","volume":"15","author":"H Gallardo-Rinc\u00f3n","year":"2021","unstructured":"Gallardo-Rinc\u00f3n H, Cantoral A, Arrieta A, Espinal C, Magnus MH, Palacios C, et al. Review: Type 2 diabetes in Latin America and the Caribbean: Regional and country comparison on prevalence, trends, costs and expanded prevention. Prim Care Diabetes 1 de abril de. 2021;15(2):352\u20139. https:\/\/doi.org\/10.1016\/j.pcd.2020.10.001. PubMed PMID: 33077379.","journal-title":"Prim Care Diabetes 1 de abril de"},{"issue":"2","key":"2157_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF00262007","volume":"20","author":"AH Barnett","year":"1981","unstructured":"Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia febrero de. 1981;20(2):87\u201393. doi:10.1007\/BF00262007 PubMed PMID: 7193616.","journal-title":"Diabetologia febrero de"},{"key":"2157_CR3","first-page":"201","volume-title":"The Genetics of Diabetes mellitus","author":"J K\u00f6bberling","year":"1982","unstructured":"K\u00f6bberling J, Tillil H. Empirical risk figures for first degree relatives of non-insulin dependent diabetics. The Genetics of Diabetes mellitus. En: London: Academic; 1982. pp. 201\u20139."},{"issue":"3","key":"2157_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-2125","volume":"51","author":"M McCarthy","year":"2001","unstructured":"McCarthy M, Menzel S. The genetics of type 2 diabetes. Br J Clin Pharmacol marzo de. 2001;51(3):195\u20139. https:\/\/doi.org\/10.1046\/j.1365-2125. 2001.00346.x PubMed PMID: 11298064; PubMed Central PMCID: PMC2015023.","journal-title":"Br J Clin Pharmacol marzo de"},{"key":"2157_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12939-015-0149-z","volume":"14","author":"NR Bennett","year":"2015","unstructured":"Bennett NR, Francis DK, Ferguson TS, Hennis AJM, Wilks RJ, Harris EN, et al. Disparities in diabetes mellitus among Caribbean populations: a scoping review. Int J Equity Health 25 de febrero de. 2015;14:23. https:\/\/doi.org\/10.1186\/s12939-015-0149-z. PubMed PMID: 25889068; PubMed Central PMCID: PMC4347914.","journal-title":"Int J Equity Health 25 de febrero de"},{"key":"2157_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fpubh.2017.00329","volume":"5","author":"JM Mercader","year":"2017","unstructured":"Mercader JM, Florez JC. The Genetic Basis of Type 2 Diabetes in Hispanics and Latin Americans: Challenges and Opportunities. Front Public Health. 2017;5:329. https:\/\/doi.org\/10.3389\/fpubh.2017.00329. PubMed PMID: 29376044; PubMed Central PMCID: PMC5763127.","journal-title":"Front Public Health"},{"issue":"6","key":"2157_CR7","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1097\/HJH.0000000000002072","volume":"37","author":"P L\u00f3pez-Jaramillo","year":"2019","unstructured":"L\u00f3pez-Jaramillo P, Barbosa E, Molina DI, Sanchez R, Diaz M, Camacho PA, et al. Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome. J Hypertens junio de. 2019;37(6):1126. https:\/\/doi.org\/10.1097\/HJH.0000000000002072.","journal-title":"J Hypertens junio de"},{"key":"2157_CR8","doi-asserted-by":"publisher","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Panorama de la diabetes en la Regi\u00f3n de las Am\u00e9ricas [Technical reports] [Internet]. OPS. 2023 [citado 28 de septiembre de 2025]. Report No. Disponible en: https:\/\/iris.paho.org\/handle\/10665.2\/57197https:\/\/doi.org\/10.37774\/9789275326336","DOI":"10.37774\/9789275326336"},{"issue":"4","key":"2157_CR9","doi-asserted-by":"publisher","first-page":"e23255","DOI":"10.1002\/ajhb.23255","volume":"31","author":"CC Barbosa","year":"2019","unstructured":"Barbosa CC, Sacuena ESR, Pinto AM, Cardoso-Costa GL, Guerreiro JF. Anthropometric and metabolic profile of a Brazilian Amerindian group: The Xikrin (Mebeng\u00f4kre). Am J Hum Biol Off J Hum Biol Counc julio de. 2019;31(4):e23255. https:\/\/doi.org\/10.1002\/ajhb.23255. PubMed PMID: 31115128.","journal-title":"Am J Hum Biol Off J Hum Biol Counc julio de"},{"issue":"1","key":"2157_CR10","first-page":"35","volume":"24","author":"AL Dal Fabbro","year":"2014","unstructured":"Dal Fabbro AL, Franco LJ, da Silva AS, Sartorelli DS, Soares LP, Franco LF, et al. High prevalence of type 2 diabetes mellitus in Xavante Indians from Mato Grosso, Brazil. Ethn Dis. 2014;24(1):35\u201340. PubMed PMID: 24620446.","journal-title":"Ethn Dis"},{"issue":"1","key":"2157_CR11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1186\/s12889-018-6160-8","volume":"18","author":"ZA de Souza Filho","year":"2018","unstructured":"de Souza Filho ZA, Ferreira AA, Dos Santos J, Meira KC, Pierin AMG. Cardiovascular risk factors with an emphasis on hypertension in the Mura Indians from Amazonia. BMC Public Health 13 de noviembre de. 2018;18(1):1251. https:\/\/doi.org\/10.1186\/s12889-018-6160-8. PubMed PMID: 30424745; PubMed Central PMCID: PMC6234583.","journal-title":"BMC Public Health 13 de noviembre de"},{"issue":"9","key":"2157_CR12","doi-asserted-by":"publisher","first-page":"e0255730","DOI":"10.1371\/journal.pone.0255730","volume":"16","author":"HLM Gomes","year":"2021","unstructured":"Gomes HLM, Sombra NM, Cordeiro ED, de Filho O, de Toledo ZA, das N, Mainbourg N. Glycemic profile and associated factors in indigenous Munduruku, Amazonas. PLoS ONE. 2021;16(9):e0255730. https:\/\/doi.org\/10.1371\/journal.pone.0255730. PubMed PMID: 34478451; PubMed Central PMCID: PMC8415589.","journal-title":"PLoS ONE"},{"issue":"4","key":"2157_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s40615-019-00573-0","volume":"6","author":"JA Campbell","year":"2019","unstructured":"Campbell JA, Walker RJ, Dawson AZ, Egede LE. Prevalence of Diabetes, Prediabetes, and Obesity in the Indigenous Kuna Population of Panam\u00e1. J Racial Ethn Health Disparities agosto de. 2019;6(4):743\u201351. https:\/\/doi.org\/10.1007\/s40615-019-00573-0. PubMed PMID: 30805801.","journal-title":"J Racial Ethn Health Disparities agosto de"},{"issue":"1","key":"2157_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5334\/gh.1171","volume":"17","author":"E Steinbrook","year":"2022","unstructured":"Steinbrook E, Flood D, Barnoya J, Montano CM, Miller AC, Rohloff P. Prevalence of Hypertension, Diabetes, and Other Cardiovascular Disease Risk Factors in Two Indigenous Municipalities in Rural Guatemala: A Population-Representative Survey. Glob Heart. 2022;17(1):82. https:\/\/doi.org\/10.5334\/gh.1171. PubMed PMID: 36578912; PubMed Central PMCID: PMC9695220.","journal-title":"Glob Heart"},{"issue":"1","key":"2157_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.17533\/udea.iatreia.18535","volume":"28","author":"JUC Bedoya","year":"2015","unstructured":"Bedoya JUC, Botero JD, Gonz\u00e1lez CAN, Molina DCR, Gracia JR, Pineda AFG, et al. Prevalencia de factores de riesgo cardiovascular en ind\u00edgenas embera-cham\u00ed de Cristian\u00eda (Jard\u00edn), Antioquia. Iatreia. 2015;28(1):5\u201316. https:\/\/doi.org\/10.17533\/udea.iatreia.18535. Located at: Jard\u00edn, Antioquia (Colombia).","journal-title":"Iatreia"},{"issue":"1","key":"2157_CR16","doi-asserted-by":"publisher","first-page":"e000186","DOI":"10.1136\/bmjdrc-2015-000186","volume":"4","author":"ISK Krishnadath","year":"2016","unstructured":"Krishnadath ISK, Nahar-van Venrooij LM, Jaddoe VWV, Toelsie JR. Ethnic differences in prediabetes and diabetes in the Suriname Health Study. BMJ Open Diabetes Res Care 29 de junio de. 2016;4(1):e000186. https:\/\/doi.org\/10.1136\/bmjdrc-2015-000186. PubMed PMID: 27403324; PubMed Central PMCID: PMC4932318.","journal-title":"BMJ Open Diabetes Res Care 29 de junio de"},{"issue":"10","key":"2157_CR17","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.4067\/s0034-98872004001000005","volume":"132","author":"EP Carrasco","year":"2004","unstructured":"Carrasco EP, P\u00e9rez FB, Angel BB, Albala CB, Santos JLM, Larenas GY, et al. [Prevalence of type 2 diabetes and obesity in two Chilean aboriginal populations living in urban zones]. Rev Med Chil octubre de. 2004;132(10):1189\u201397. https:\/\/doi.org\/10.4067\/s0034-98872004001000005. PubMed PMID: 15631206.","journal-title":"Rev Med Chil octubre de"},{"key":"2157_CR18","doi-asserted-by":"publisher","unstructured":"Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 15 de julio de 2023;402(10397):203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6 PubMed PMID: 37356446.","DOI":"10.1016\/S0140-6736("},{"issue":"7486","key":"2157_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12828","volume":"506","author":"AL Williams","year":"2014","unstructured":"SIGMA Type 2 Diabetes Consortium, Williams AL, Jacobs SBR, Moreno-Mac\u00edas H, Huerta-Chagoya A, Churchhouse C, et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nat 6 de febrero de. 2014;506(7486):97\u2013101. https:\/\/doi.org\/10.1038\/nature12828. PubMed PMID: 24390345; PubMed Central PMCID: PMC4127086.","journal-title":"Nat 6 de febrero de"},{"issue":"11","key":"2157_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11892-020-01341-9","volume":"20","author":"ML Avil\u00e9s-Santa","year":"2020","unstructured":"Avil\u00e9s-Santa ML, Monroig-Rivera A, Soto-Soto A, Lindberg NM. Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent. Curr Diab Rep 10 de octubre de. 2020;20(11):62. https:\/\/doi.org\/10.1007\/s11892-020-01341-9. PubMed PMID: 33037442; PubMed Central PMCID: PMC7546937.","journal-title":"Curr Diab Rep 10 de octubre de"},{"key":"2157_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.puhe.2024.05.009","volume":"233","author":"I Ilic","year":"2024","unstructured":"Ilic I, Ilic M. The burden of type 2 diabetes mellitus in Latin America, 1990\u20132019: findings from the Global Burden of Disease study. Public Health agosto de. 2024;233:74\u201382. https:\/\/doi.org\/10.1016\/j.puhe.2024.05.009. PubMed PMID: 38852206.","journal-title":"Public Health agosto de"},{"key":"2157_CR22","doi-asserted-by":"publisher","unstructured":"Moucheraud C, Lenz C, Latkovic M, Wirtz VJ. The costs of diabetes treatment in low- and middle-income countries: a systematic review. BMJ Glob Health 27 de febrero de. 2019;4(1). https:\/\/doi.org\/10.1136\/bmjgh-2018-001258. PubMed PMID:.","DOI":"10.1136\/bmjgh-2018-001258"},{"issue":"7","key":"2157_CR23","doi-asserted-by":"publisher","first-page":"e68443","DOI":"10.1371\/journal.pone.0068443","volume":"8","author":"A Arredondo","year":"2013","unstructured":"Arredondo A, Reyes G. Health disparities from economic burden of diabetes in middle-income countries: evidence from M\u00e9xico. PLoS ONE. 2013;8(7):e68443. https:\/\/doi.org\/10.1371\/journal.pone.0068443. PubMed PMID: 23874629; PubMed Central PMCID: PMC3709919.","journal-title":"PLoS ONE"},{"issue":"4","key":"2157_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/1753-0407.12633","volume":"10","author":"A Arredondo","year":"2018","unstructured":"Arredondo A, Azar A. Challenges of the economic and social effects of diabetes in low- and middle-income countries. J Diabetes abril de. 2018;10(4):344\u20135. https:\/\/doi.org\/10.1111\/1753-0407.12633. PubMed PMID: 29206347.","journal-title":"J Diabetes abril de"},{"issue":"4","key":"2157_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2337\/dc19-1782","volume":"43","author":"JA Seiglie","year":"2020","unstructured":"Seiglie JA, Marcus ME, Ebert C, Prodromidis N, Geldsetzer P, Theilmann M, et al. Diabetes Prevalence and Its Relationship With Education, Wealth, and BMI in 29 Low- and Middle-Income Countries. Diabetes Care abril de. 2020;43(4):767\u201375. https:\/\/doi.org\/10.2337\/dc19-1782. PubMed PMID: 32051243; PubMed Central PMCID: PMC7085810.","journal-title":"Diabetes Care abril de"},{"key":"2157_CR26","unstructured":"Institute for Health Metrics and Evaluation. Institute for Health Metrics and Evaluation [Internet]. 2023 [citado 28 de febrero de 2026]. GBD Compare. Disponible en: https:\/\/vizhub.healthdata.org\/gbd-compare"},{"issue":"10027","key":"2157_CR27","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(","volume":"387","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet Lond Engl 9 de abril de. 2016;387(10027):1513\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(. 16)00618-8 PubMed PMID: 27061677; PubMed Central PMCID: PMC5081106.","journal-title":"Lancet Lond Engl 9 de abril de"},{"issue":"10064","key":"2157_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","volume":"389","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2017","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants. Lancet Lond Engl 7 de enero de. 2017;389(10064):37\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(16)31919-5. PubMed PMID: 27863813; PubMed Central PMCID: PMC5220163.","journal-title":"Lancet Lond Engl 7 de enero de"},{"issue":"4","key":"2157_CR29","doi-asserted-by":"publisher","first-page":"e3139","DOI":"10.1002\/dmrr.3139","volume":"35","author":"RM Carrillo-Larco","year":"2019","unstructured":"Carrillo-Larco RM, Barengo NC, Albitres-Flores L, Bernabe-Ortiz A. The risk of mortality among people with type 2 diabetes in Latin America: A systematic review and meta-analysis of population-based cohort studies. Diabetes Metab Res Rev mayo de. 2019;35(4):e3139. https:\/\/doi.org\/10.1002\/dmrr.3139. PubMed PMID: 30761721.","journal-title":"Diabetes Metab Res Rev mayo de"},{"issue":"10","key":"2157_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877","volume":"20","author":"ND Wong","year":"2023","unstructured":"Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol octubre de. 2023;20(10):685\u201395. https:\/\/doi.org\/10.1038\/s41569-023-00877. -z PubMed PMID: 37193856.","journal-title":"Nat Rev Cardiol octubre de"},{"key":"2157_CR31","doi-asserted-by":"publisher","unstructured":"Gyldenkerne C, Mortensen MB, Kahlert J, Thrane PG, Warnakula Olesen KK, S\u00f8rensen HT et al. 10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus. J Am Coll Cardiol. 17 de octubre de 2023;82(16):1583\u201394. https:\/\/doi.org\/10.1016\/j.jacc.2023.08.015 PubMed PMID: 37821168.","DOI":"10.1016\/j.jacc.2023.08"},{"key":"2157_CR32","doi-asserted-by":"publisher","unstructured":"Anderson TS, Wilson LM, Sussman JB, Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations. JAMA Intern Med. 1 de agosto de. 2024;184(8):963\u2009\u2013\u200970. https:\/\/doi.org\/10.1001\/jamainternmed.2024.1302 PubMed PMID: 38856978; PubMed Central PMCID: PMC11165411.","DOI":"10.1001\/jamainternmed.2024.1302"},{"issue":"1","key":"2157_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12913-016-1365-y","volume":"16","author":"L Munch","year":"2016","unstructured":"Munch L, Arreskov AB, Sperling M, Overgaard D, Knop FK, Vilsb\u00f8ll T, et al. Risk stratification by endocrinologists of patients with type 2 diabetes in a Danish specialised outpatient clinic: a cross-sectional study. BMC Health Serv Res 9 de abril de. 2016;16(1):124. https:\/\/doi.org\/10.1186\/s12913-016-1365-y.","journal-title":"BMC Health Serv Res 9 de abril de"},{"key":"2157_CR34","doi-asserted-by":"publisher","unstructured":"Ahmad A, Lim LL, Morieri ML, Tam CH, ting, Cheng F, Chikowore T et al. Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis. Commun Med. 22 de enero de. 2024;4(1):11. https:\/\/doi.org\/10.1038\/s43856-023-00429-z","DOI":"10.1038\/s43856-023-00429-z"},{"key":"2157_CR35","doi-asserted-by":"publisher","first-page":"109089","DOI":"10.1016\/j.diabres.2021.109089","volume":"184","author":"A Galbete","year":"2022","unstructured":"Galbete A, Tamayo I, Librero J, Enguita-Germ\u00e1n M, Cambra K, Ib\u00e1\u00f1ez-Beroiz B, et al. Cardiovascular risk in patients with type 2 diabetes: A systematic review of prediction models. Diabetes Res Clin Pract febrero de. 2022;184:109089. https:\/\/doi.org\/10.1016\/j.diabres.2021.109089. PubMed PMID: 34648890.","journal-title":"Diabetes Res Clin Pract febrero de"},{"issue":"1","key":"2157_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-024-03284-4","volume":"22","author":"S Wambua","year":"2024","unstructured":"Wambua S, Singh M, Okoth K, Snell KIE, Riley RD, Yau C, et al. Association between pregnancy-related complications and development of type 2 diabetes and hypertension in women: an umbrella review. BMC Med 14 de febrero de. 2024;22(1):66. https:\/\/doi.org\/10.1186\/s12916-024-03284-4. PubMed PMID: 38355631; PubMed Central PMCID: PMC10865714.","journal-title":"BMC Med 14 de febrero de"},{"issue":"1","key":"2157_CR37","first-page":"93","volume":"230","author":"K Zhu","year":"2024","unstructured":"Zhu K, Wactawski-Wende J, Mendola P, Parikh NI, LaMonte MJ, Barnabei VM, et al. Adverse pregnancy outcomes and risk of type 2 diabetes in postmenopausal women. Am J Obstet Gynecol enero de. 2024;230(1):e1\u201393. https:\/\/doi.org\/10.1016\/j.ajog.2023.07.030. PubMed PMID: 37490991; PubMed Central PMCID: PMC10803644. 19.","journal-title":"Am J Obstet Gynecol enero de"},{"key":"2157_CR38","doi-asserted-by":"publisher","unstructured":"Scilletta S, Di Marco M, Miano N, Capuccio S, Musmeci M, Bosco G et al. Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? Cardiovasc Diabetol. 21 de mayo de. 2025;24(1):222. https:\/\/doi.org\/10.1186\/s12933-025-02769-7 PubMed PMID: 40399956; PubMed Central PMCID: PMC12096474.","DOI":"10.1186\/s12933-025-02769-7"},{"issue":"28","key":"2157_CR39","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","volume":"44","author":"SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration","year":"2023","unstructured":"SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J 29 de mayo de. 2023;44(28):2544\u201356. https:\/\/doi.org\/10.1093\/eurheartj\/ehad260. PubMed PMID: 37247330; PubMed Central PMCID: PMC10361012.","journal-title":"Eur Heart J 29 de mayo de"},{"issue":"11","key":"2157_CR40","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1111\/dom.70043","volume":"27","author":"X Li","year":"2025","unstructured":"Li X, Zhao W, Zhao L, Sun T, Pan H, Wang D. Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation. Diabetes Obes Metab noviembre de. 2025;27(11):6470\u20139. https:\/\/doi.org\/10.1111\/dom.70043. PubMed PMID: 40832797.","journal-title":"Diabetes Obes Metab noviembre de"},{"key":"2157_CR41","doi-asserted-by":"publisher","unstructured":"Lopez-Lopez JP, Garcia-Pena AA, Martinez-Bello D, Gonzalez AM, Perez-Mayorga M, Mu\u00f1oz Velandia OM et al. External validation and comparison of six cardiovascular risk prediction models in the Prospective Urban Rural Epidemiology (PURE)-Colombia study. Eur J Prev Cardiol. 12 de mayo de 2025;32(7):564\u201372. https:\/\/doi.org\/10.1093\/eurjpc\/zwae242 PubMed PMID: 39041366; PubMed Central PMCID: PMC12066169.","DOI":"10.1093\/eurjpc\/zwae"},{"key":"2157_CR42","doi-asserted-by":"publisher","unstructured":"Misra S, Khunti K, Goyal A, Gable D, Armocida B, Tandon N et al. Managing early-onset type 2 diabetes in the individual and at the population level. Lancet Lond Engl. 28 de junio de 2025;405(10497):2341\u201354. https:\/\/doi.org\/10.1016\/S0140-6736(25)01067-0 PubMed PMID: 40570864.","DOI":"10.1016\/S0140-6736"},{"key":"2157_CR43","unstructured":"Rout P, Jialal I, Diabetic Nephropathy. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [citado 2 de octubre de 2025]. Disponible en: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534200\/ PubMed PMID: 30480939."},{"key":"2157_CR44","doi-asserted-by":"publisher","unstructured":"Montero N, Oliveras L, Mart\u00ednez-Castelao A, Gorriz JL, Soler MJ, Fern\u00e1ndez-Fern\u00e1ndez B et al. Gu\u00eda de pr\u00e1ctica cl\u00ednica sobre detecci\u00f3n y manejo de la enfermedad renal diab\u00e9tica: documento de consenso de la Sociedad Espa\u00f1ola de Nefrolog\u00eda. Nefrolog\u00eda. 1 de abril de 2025;Gu\u00eda de pr\u00e1ctica cl\u00ednica sobre detecci\u00f3n y manejo de la enfermedad renal diab\u00e9tica: documento de consenso de la Sociedad Espa\u00f1ola de Nefrolog\u00eda45:1\u201326. https:\/\/doi.org\/10.1016\/j.nefro.2024.11.002","DOI":"10.1016\/j.nefro.2024.11.002"},{"issue":"5S","key":"2157_CR45","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint","volume":"102","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","year":"2022","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int noviembre de. 2022;102(5S):S1\u2013127. https:\/\/doi.org\/10.1016\/j.kint. 2022.06.008 PubMed PMID: 36272764.","journal-title":"Kidney Int noviembre de"},{"issue":"5","key":"2157_CR46","doi-asserted-by":"publisher","first-page":"e70064","DOI":"10.1002\/dmrr.70064","volume":"41","author":"D Moriconi","year":"2025","unstructured":"Moriconi D, Nannipieri M, Jadoon M, Solini A, Bruno RM. Albumin-To\u2010Creatinine Ratio Underestimates True 24\u2010Hour Albuminuria in Obesity: Clinical Relevance for Vascular Risk Stratification. Diabetes Metab Res Rev julio de. 2025;41(5):e70064. https:\/\/doi.org\/10.1002\/dmrr.70064. PubMed PMID: 40557880; PubMed Central PMCID: PMC12188699.","journal-title":"Diabetes Metab Res Rev julio de"},{"key":"2157_CR47","unstructured":"Serrano JE, Vigara JCR, Mart\u00edn JC, Fern\u00e1ndez MA. Albuminuria con un aumento leve (10\u201329\u00a0mg\/g): un factor de riesgo emergente para la enfermedad renal y la morbimortalidad sist\u00e9mica."},{"issue":"4S","key":"2157_CR48","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int abril de. 2024;105(4S):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018. PubMed PMID: 38490803.","journal-title":"Kidney Int abril de"},{"key":"2157_CR49","doi-asserted-by":"publisher","unstructured":"Agarwal R, Filippatos G, Pitt B, Anker SD, Rossing P, Joseph A et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J 10 de febrero de 2022;43(6):474\u201384. https:\/\/doi.org\/10.1093\/eurheartj\/ehab777 PubMed PMID: 35023547; PubMed Central PMCID: PMC8830527.","DOI":"10.1093\/eurheartj\/ehab777"},{"issue":"23","key":"2157_CR50","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 2 de diciembre de. 2020;383(23):2219\u201329. https:\/\/doi.org\/10.1056\/NEJMoa2025845.","journal-title":"N Engl J Med 2 de diciembre de"},{"key":"2157_CR51","doi-asserted-by":"publisher","unstructured":"Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P et al. Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. N Engl J Med. 8 de diciembre de 2021;385(24):2252\u201363. https:\/\/doi.org\/10.1056\/NEJMoa2110956","DOI":"10.1056\/NEJMoa2110956"},{"key":"2157_CR52","doi-asserted-by":"publisher","unstructured":"Heerspink HJL, Birkenfeld AL, Cherney DZI, Colhoun HM, Ji L, Mathieu C et al. Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial. Diabetes Res Clin Pract 1 de octubre de 2023;204. https:\/\/doi.org\/10.1016\/j.diabres.2023.110908 PubMed PMID: 37805000.","DOI":"10.1016\/j.diabres.2023.110908"},{"key":"2157_CR53","doi-asserted-by":"publisher","unstructured":"Huang H, Wu Y, Ye H, Li J, Chen L, Huang X. Risk prediction models for diabetic retinopathy: a systematic review. Front Endocrinol 11 de julio de. 2025;16. https:\/\/doi.org\/10.3389\/fendo.2025.1556049.","DOI":"10.3389\/fendo.2025.1556049"},{"key":"2157_CR54","unstructured":"Shukla UV, Tripathy K, Diabetic Retinopathy. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [citado 28 de septiembre de 2025]. Disponible en: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560805\/ PubMed PMID: 32809640."},{"issue":"1","key":"2157_CR55","doi-asserted-by":"publisher","first-page":"2413920","DOI":"10.1080\/07853890.2024.2413920","volume":"56","author":"H Guo","year":"2024","unstructured":"Guo H, Han F, Qu JR, Pan C, qing, Sun B, Chen LM. Scoring and validation of a simple model for predicting diabetic retinopathy in patients with type 2 diabetes based on a meta-analysis approach of 21 cohorts. Ann Med 31 de diciembre de. 2024;56(1):2413920. https:\/\/doi.org\/10.1080\/07853890.2024.2413920. PubMed PMID: 39392052.","journal-title":"Ann Med 31 de diciembre de"},{"key":"2157_CR56","unstructured":"Ministerio de Salud P\u00fablica. Gu\u00eda de Pr\u00e1ctica Cl\u00ednica (GPC) de Diabetes mellitus tipo 2 [Internet]. 2017 [citado 30 de septiembre de 2025]. Disponible en: https:\/\/www.salud.gob.ec\/wp-content\/uploads\/downloads\/2017\/05\/Diabetes-mellitus_GPC.pdf"},{"issue":"2","key":"2157_CR57","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ijcard.2011.12.100","volume":"167","author":"R Qin","year":"2013","unstructured":"Qin R, Chen T, Lou Q, Yu D. Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies. Int J Cardiol 31 de julio de. 2013;167(2):342\u201350. https:\/\/doi.org\/10.1016\/j.ijcard.2011.12.100. PubMed PMID: 22251416.","journal-title":"Int J Cardiol 31 de julio de"},{"issue":"5","key":"2157_CR58","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4239\/wjd.v15.i5.797","volume":"15","author":"JM Pappachan","year":"2024","unstructured":"Pappachan JM, Fernandez CJ, Ashraf AP. Rising tide: The global surge of type 2 diabetes in children and adolescents demands action now. World J Diabetes 15 de mayo de. 2024;15(5):797\u2013809. https:\/\/doi.org\/10.4239\/wjd.v15.i5.797. PubMed PMID: 38766426; PubMed Central PMCID: PMC11099374.","journal-title":"World J Diabetes 15 de mayo de"},{"issue":"4","key":"2157_CR59","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4236\/jdm.2011.14012","volume":"1","author":"S Yaturu","year":"2011","unstructured":"Yaturu S. Obesity and type 2 diabetes. J Diabetes Mellit 8 de noviembre de. 2011;1(4):79\u201395. https:\/\/doi.org\/10.4236\/jdm.2011.14012.","journal-title":"J Diabetes Mellit 8 de noviembre de"},{"issue":"10","key":"2157_CR60","doi-asserted-by":"publisher","first-page":"994","DOI":"10.4158\/EP-2018-0473","volume":"25","author":"CH Chen-Ku","year":"2019","unstructured":"Chen-Ku CH, Gonzalez-Galvez G, V\u00e1squez M, Fuente G, Nakazone MA, Silva Giordano AI, VASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES: PREVALENCE AND COMORBIDITIES IN 6 COUNTRIES OF LATIN AMERICA (A COHORT OF THE DISCOVER STUDY PROGRAM), et al. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol octubre de. 2019;25(10):994\u20131002. https:\/\/doi.org\/10.4158\/EP-2018-0473. PubMed PMID: 31170372.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol octubre de"},{"key":"2157_CR61","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes\u20132025. Diabetes Care. 9 de diciembre de 2024;48(Supplement_1):S167-80. https:\/\/doi.org\/10.2337\/dc25-S008","DOI":"10.2337\/dc25-S008"},{"issue":"8","key":"2157_CR62","doi-asserted-by":"publisher","first-page":"e0201568","DOI":"10.1371\/journal.pone.0201568","volume":"13","author":"AH Xiang","year":"2018","unstructured":"Xiang AH, Black MH, Shu YH, Wu J, MacKay A, Koebnick C, et al. Association of weight gain and fifteen adipokines with declining beta-cell function in Mexican Americans. PLOS ONE 13 de agosto de. 2018;13(8):e0201568. https:\/\/doi.org\/10.1371\/journal.pone.0201568.","journal-title":"PLOS ONE 13 de agosto de"},{"issue":"1","key":"2157_CR63","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12939-023-01939-x","volume":"22","author":"M Puig-Garc\u00eda","year":"2023","unstructured":"Puig-Garc\u00eda M, Caicedo-Monta\u00f1o C, M\u00e1rquez-Figueroa M, Chilet-Rosell E, Montalvo-Villacis G, Benazizi-Dahbi I, et al. Prevalence and gender disparities of type 2 diabetes mellitus and obesity in Esmeraldas, Ecuador: a population-based survey in a hard-to-reach setting. Int J Equity Health 1 de julio de. 2023;22(1):124. https:\/\/doi.org\/10.1186\/s12939-023-01939-x.","journal-title":"Int J Equity Health 1 de julio de"},{"issue":"25","key":"2157_CR64","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1161\/CIRCULATIONAHA.106.673756","volume":"116","author":"D Canoy","year":"2007","unstructured":"Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 18 de diciembre de. 2007;116(25):2933\u201343. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.673756. PubMed PMID: 18071080.","journal-title":"Circulation 18 de diciembre de"},{"issue":"3","key":"2157_CR65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrgastro.2011.4","volume":"8","author":"MM Smits","year":"2011","unstructured":"Smits MM, van Geenen EJM. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol marzo de. 2011;8(3):169\u201377. https:\/\/doi.org\/10.1038\/nrgastro.2011.4.","journal-title":"Nat Rev Gastroenterol Hepatol marzo de"},{"issue":"4","key":"2157_CR66","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00125-020-05362-7","volume":"64","author":"E Polemiti","year":"2021","unstructured":"Polemiti E, Baudry J, Kuxhaus O, J\u00e4ger S, Bergmann MM, Weikert C, et al. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study. Diabetologia 1 de abril de. 2021;64(4):814\u201325. https:\/\/doi.org\/10.1007\/s00125-020-05362-7.","journal-title":"Diabetologia 1 de abril de"},{"issue":"3","key":"2157_CR67","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.pcd.2022.03.009","volume":"16","author":"F Moosaie","year":"2022","unstructured":"Moosaie F, Ghaemi F, Mechanick JI, Shadnoush M, Firouzabadi FD, Kermanchi J, et al. Obesity and Diabetic Complications: A Study from the Nationwide Diabetes Report of the National Program for Prevention and Control of Diabetes (NPPCD-2021) Implications for Action on Multiple Scales. Prim Care Diabetes 1 de junio de. 2022;16(3):422\u20139. https:\/\/doi.org\/10.1016\/j.pcd.2022.03.009. PubMed PMID: 35396199.","journal-title":"Prim Care Diabetes 1 de junio de"},{"issue":"3","key":"2157_CR68","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.diabres.2014.09","volume":"106","author":"MK Kim","year":"2014","unstructured":"Kim MK, Chun HJ, Park JH, Yeo DM, Baek KH, Song KH, et al. The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes. Diabetes Res Clin Pract 1 de diciembre de. 2014;106(3):590\u20136. https:\/\/doi.org\/10.1016\/j.diabres.2014.09. .005 PubMed PMID: 25444353.","journal-title":"Diabetes Res Clin Pract 1 de diciembre de"},{"key":"2157_CR69","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0258","author":"DN Hukportie","year":"2022","unstructured":"Hukportie DN, Li FR, Zhou R, Zheng JZ, Wu XX, Wu XB. Diabetes Metab J septiembre de. 2022;46(5):767\u201380. https:\/\/doi.org\/10.4093\/dmj.2021.0258. PubMed PMID: 35584801; PubMed Central PMCID: PMC9532173. Waist Circumference and Body Mass Index Variability and Incident Diabetic Microvascular Complications: A Post Hoc Analysis of ACCORD Trial."},{"issue":"6","key":"2157_CR70","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1210\/clinem\/dgac","volume":"107","author":"J Lu","year":"2022","unstructured":"Lu J, Liu X, Jiang S, Kan S, An Y, Zheng C, et al. Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study. J Clin Endocrinol Metab 17 de mayo de. 2022;107(6):1599\u2013608. https:\/\/doi.org\/10.1210\/clinem\/dgac. 057 PubMed PMID: 35191949.","journal-title":"J Clin Endocrinol Metab 17 de mayo de"},{"issue":"3","key":"2157_CR71","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/ijms19030802","volume":"19","author":"P Severino","year":"2018","unstructured":"Severino P, D\u2019Amato A, Netti L, Pucci M, De Marchis M, Palmirotta R, et al. Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels. Int J Mol Sci 10 de marzo de. 2018;19(3):802. https:\/\/doi.org\/10.3390\/ijms19030802. PubMed PMID: 29534462; PubMed Central PMCID: PMC5877663.","journal-title":"Int J Mol Sci 10 de marzo de"},{"key":"2157_CR72","doi-asserted-by":"crossref","unstructured":"Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 23 de julio de 1998;339(4):229\u201334. doi:10.1056\/NEJM199807233390404 PubMed PMID: 9673301.","DOI":"10.1056\/NEJM199807233390404"},{"issue":"12","key":"2157_CR73","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1136\/hrt.2006.097956","volume":"93","author":"A Norhammar","year":"2007","unstructured":"Norhammar A, Lindb\u00e4ck J, Ryd\u00e9n L, Wallentin L, Stenestrand U. Improved but still high short- and long\u2010term mortality rates after myocardial infarction in patients with diabetes mellitus: a time\u2010trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart diciembre de. 2007;93(12):1577\u201383. https:\/\/doi.org\/10.1136\/hrt.2006.097956. PubMed PMID: 17237125; PubMed Central PMCID: PMC2095772.","journal-title":"Heart diciembre de"},{"key":"2157_CR74","doi-asserted-by":"publisher","first-page":"1401569","DOI":"10.3389\/fcvm.2024.1401569","volume":"11","author":"F Bouisset","year":"2024","unstructured":"Bouisset F, Bataille V, Schiele F, Puymirat E, Fayol A, Simon T, et al. Type 2 diabetes mellitus in acute myocardial infarction: a persistent significant burden on long-term mortality. Front Cardiovasc Med. 2024;11:1401569. https:\/\/doi.org\/10.3389\/fcvm.2024.1401569. PubMed PMID: 38932992; PubMed Central PMCID: PMC11204119.","journal-title":"Front Cardiovasc Med"},{"key":"2157_CR75","doi-asserted-by":"publisher","first-page":"644189","DOI":"10.3389\/fcvm.2021.644189","volume":"8","author":"J Cui","year":"2021","unstructured":"Cui J, Liu Y, Li Y, Xu F, Liu Y. Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective. Front Cardiovasc Med 24 de febrero de. 2021;8:644189. https:\/\/doi.org\/10.3389\/fcvm.2021.644189. PubMed PMID: 33718461; PubMed Central PMCID: PMC7943438.","journal-title":"Front Cardiovasc Med 24 de febrero de"},{"key":"2157_CR76","doi-asserted-by":"publisher","unstructured":"Mosenzon O, Cheng AY, Rabinstein AA, Sacco S. Diabetes and Stroke: What Are the Connections? J Stroke. 3 de enero de. 2023;25(1):26\u201338. https:\/\/doi.org\/10.5853\/jos.2022.02306","DOI":"10.5853\/jos.2022.02306"},{"issue":"4","key":"2157_CR77","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.amjms.2016.01.011","volume":"351","author":"R Chen","year":"2016","unstructured":"Chen R, Ovbiagele B, Feng W. Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes. Am J Med Sci abril de. 2016;351(4):380\u20136. https:\/\/doi.org\/10.1016\/j.amjms.2016.01.011. PubMed PMID: 27079344; PubMed Central PMCID: PMC5298897.","journal-title":"Am J Med Sci abril de"},{"key":"2157_CR78","doi-asserted-by":"publisher","unstructured":"Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M et al. Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways. Cureus 15(9):e45835. https:\/\/doi.org\/10.7759\/cureus.45835 PubMed PMID: 37881393; PubMed Central PMCID: PMC10594042.","DOI":"10.7759\/cureus.45835"},{"issue":"16","key":"2157_CR79","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3390\/healthcare13161967","volume":"13","author":"A Przyby\u0142owski","year":"2025","unstructured":"Przyby\u0142owski A, G\u00f3rski M, Gwio\u017adzik W, Polaniak R. Redefining Obesity: A Narrative Review of Diagnostic Evolution, Therapeutic Strategies and Psychosocial Determinants. Healthc 11 de agosto de. 2025;13(16):1967. https:\/\/doi.org\/10.3390\/healthcare13161967. PubMed PMID: 40868582; PubMed Central PMCID: PMC12385716.","journal-title":"Healthc 11 de agosto de"},{"issue":"3","key":"2157_CR80","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1514009","volume":"376","author":"SB Heymsfield","year":"2017","unstructured":"Heymsfield SB, Wadden TA. Mechanisms, Pathophysiology, and Management of Obesity. N Engl J Med 19 de enero de. 2017;376(3):254\u201366. https:\/\/doi.org\/10.1056\/NEJMra1514009.","journal-title":"N Engl J Med 19 de enero de"},{"issue":"4","key":"2157_CR81","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S2213-8587(23)00385-6","volume":"12","author":"ME Lean","year":"2024","unstructured":"Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes Endocrinol 1 de abril de. 2024;12(4):233\u201346. https:\/\/doi.org\/10.1016\/S2213-8587(23)00385-6.","journal-title":"Lancet Diabetes Endocrinol 1 de abril de"},{"issue":"1","key":"2157_CR82","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12933-022-01670-x","volume":"21","author":"T Qiao","year":"2022","unstructured":"Qiao T, Luo T, Pei H, Yimingniyazi B, Aili D, Aimudula A, et al. Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol 1 de noviembre de. 2022;21(1):225. https:\/\/doi.org\/10.1186\/s12933-022-01670-x.","journal-title":"Cardiovasc Diabetol 1 de noviembre de"},{"issue":"7","key":"2157_CR83","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dci24-0094","volume":"48","author":"K Cusi","year":"2025","unstructured":"Cusi K, Abdelmalek MF, Apovian CM, Balapattabi K, Bannuru RR, Barb D, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care 1 de julio de. 2025;48(7):1057\u201382. https:\/\/doi.org\/10.2337\/dci24-0094. PubMed PMID: 40434108.","journal-title":"Diabetes Care 1 de julio de"},{"issue":"6","key":"2157_CR84","doi-asserted-by":"publisher","first-page":"100706","DOI":"10.1016\/j.aohep.2022.100706","volume":"27","author":"YAO Rojas","year":"2022","unstructured":"Rojas YAO, Cuellar CLV, Barr\u00f3n KMA, Arab JP, Miranda AL. Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis. Ann Hepatol. 2022;27(6):100706. https:\/\/doi.org\/10.1016\/j.aohep.2022.100706. PubMed PMID: 35427804.","journal-title":"Ann Hepatol"},{"issue":"2","key":"2157_CR85","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0021-9150(00)00424-X","volume":"153","author":"I Lemieux","year":"2000","unstructured":"Lemieux I, Couillard C, Pascot A, Bergeron N, Prud\u2019homme D, Bergeron J, et al. The small, dense LDL phenotype as a correlate of postprandial lipemia in men. Atherosclerosis 1 de diciembre de. 2000;153(2):423\u201332. https:\/\/doi.org\/10.1016\/S0021-9150(00)00424-X.","journal-title":"Atherosclerosis 1 de diciembre de"},{"key":"2157_CR86","doi-asserted-by":"publisher","unstructured":"Lee HH, Lee HA, Kim EJ, Kim HY, Kim HC, Ahn SH et al. Cardiovascular Risk From Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiometabolic Risk Factor Count, and Their Longitudinal Changes: A Nationwide Cohort Study. Am J Gastroenterol. 1 de octubre de 2025;120(10):2321\u20139. https:\/\/doi.org\/10.14309\/ajg.0000000000003274 PubMed PMID: 39787330.","DOI":"10.14309\/ajg.0000000000003274"},{"issue":"2","key":"2157_CR87","doi-asserted-by":"publisher","first-page":"101903","DOI":"10.1016\/j.aohep.2025.101903","volume":"30","author":"LA Diaz","year":"2025","unstructured":"Diaz LA, Arab JP, Idalsoaga F, Perelli J, Vega J, Dirchwolf M, et al. Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group. Ann Hepatol 13 de marzo de. 2025;30(2):101903. https:\/\/doi.org\/10.1016\/j.aohep.2025.101903. PubMed PMID: 40089151.","journal-title":"Ann Hepatol 13 de marzo de"},{"issue":"19","key":"2157_CR88","doi-asserted-by":"publisher","first-page":"9625","DOI":"10.3390\/ijms26199625","volume":"26","author":"MY Sheikh","year":"2025","unstructured":"Sheikh MY, Younus MF, Shergill A, Hasan MN. Diet and Lifestyle Interventions in Metabolic Dysfunction-Associated Fatty Liver Disease: A Comprehensive Review. Int J Mol Sci enero de. 2025;26(19):9625. https:\/\/doi.org\/10.3390\/ijms26199625.","journal-title":"Int J Mol Sci enero de"},{"issue":"6","key":"2157_CR89","doi-asserted-by":"publisher","first-page":"101709","DOI":"10.1016\/j.diabet.2025.101709","volume":"51","author":"Y Chouik","year":"2025","unstructured":"Chouik Y, Canivet CM, Julla JB, Mouillot T, Parlati L, Rouland A, et al. Management of patients with type 2 diabetes and MASLD: An overview and joint statement. Diabetes Metab 1 de noviembre de. 2025;51(6):101709. https:\/\/doi.org\/10.1016\/j.diabet.2025.101709.","journal-title":"Diabetes Metab 1 de noviembre de"},{"issue":"3","key":"2157_CR90","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7570\/jomes25017","volume":"34","author":"H Goto","year":"2025","unstructured":"Goto H, Takamura T. Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated by Diabetes: Pathophysiology and Emerging Therapies. J Obes Metab Syndr 30 de julio de. 2025;34(3):224\u201338. https:\/\/doi.org\/10.7570\/jomes25017. PubMed PMID: 40537153; PubMed Central PMCID: PMC12318698.","journal-title":"J Obes Metab Syndr 30 de julio de"},{"issue":"2","key":"2157_CR91","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11239-007-0047-3","volume":"25","author":"VL Serebruany","year":"2008","unstructured":"Serebruany VL, Malinin A, Ong S, Atar D. Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease. J Thromb Thrombolysis abril de. 2008;25(2):207\u201313. https:\/\/doi.org\/10.1007\/s11239-007-0047-3. PubMed PMID: 17530178.","journal-title":"J Thromb Thrombolysis abril de"},{"key":"2157_CR92","doi-asserted-by":"publisher","unstructured":"Hukic D, Razmara M, Forslund M, Ji Q, Hjemdahl P, Li N. High glucose levels enhance platelet activation: Involvement of multiple mechanisms. Br J Haematol. 1 de junio de 2006;133:315\u201322. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06012.x","DOI":"10.1111\/j.1365-2141.2006.06012.x"},{"issue":"2","key":"2157_CR93","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/ijms21020623","volume":"21","author":"C Barale","year":"2020","unstructured":"Barale C, Russo I. Influence of Cardiometabolic Risk Factors on Platelet Function. Int J Mol Sci enero de. 2020;21(2):623. https:\/\/doi.org\/10.3390\/ijms21020623.","journal-title":"Int J Mol Sci enero de"},{"issue":"3","key":"2157_CR94","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s11239-014-1058-5","volume":"38","author":"JH Oestreich","year":"2014","unstructured":"Oestreich JH, Steinhubl SR, Ferraris SP, Loftin CD, Akers WS. Effect of genetic variation in P2Y12 on TRAP-stimulated platelet response in healthy subjects. J Thromb Thrombolysis octubre de. 2014;38(3):372\u20139. https:\/\/doi.org\/10.1007\/s11239-014-1058-5. PubMed PMID: 24510678.","journal-title":"J Thromb Thrombolysis octubre de"},{"issue":"4","key":"2157_CR95","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/bph.16207","volume":"181","author":"EB Amoafo","year":"2024","unstructured":"Amoafo EB, Entsie P, Kang Y, Canobbio I, Liverani E. Platelet P2Y12 signalling pathway in the dysregulated immune response during sepsis. Br J Pharmacol febrero de. 2024;181(4):532\u201346. https:\/\/doi.org\/10.1111\/bph.16207. PubMed PMID: 37525937; PubMed Central PMCID: PMC10830899.","journal-title":"Br J Pharmacol febrero de"},{"issue":"7","key":"2157_CR96","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.3390\/ijms24076709","volume":"24","author":"P Entsie","year":"2023","unstructured":"Entsie P, Kang Y, Amoafo EB, Sch\u00f6neberg T, Liverani E. The Signaling Pathway of the ADP Receptor P2Y12 in the Immune System: Recent Discoveries and New Challenges. Int J Mol Sci enero de. 2023;24(7):6709. https:\/\/doi.org\/10.3390\/ijms24076709.","journal-title":"Int J Mol Sci enero de"},{"issue":"2","key":"2157_CR97","doi-asserted-by":"publisher","first-page":"101073","DOI":"10.1016\/j.jocmr.2024.101073","volume":"26","author":"N Sharrack","year":"2024","unstructured":"Sharrack N, Brown LAE, Farley J, Wahab A, Jex N, Thirunavukarasu S, et al. Occult coronary microvascular dysfunction and ischemic heart disease in patients with diabetes and heart failure. J Cardiovasc Magn Reson 1 de diciembre de. 2024;26(2):101073. https:\/\/doi.org\/10.1016\/j.jocmr.2024.101073.","journal-title":"J Cardiovasc Magn Reson 1 de diciembre de"},{"issue":"6","key":"2157_CR98","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1177\/0300060516675504","volume":"45","author":"A Kibel","year":"2017","unstructured":"Kibel A, Selthofer-Relatic K, Drenjancevic I, Bacun T, Bosnjak I, Kibel D, et al. Coronary microvascular dysfunction in diabetes mellitus. J Int Med Res diciembre de. 2017;45(6):1901\u201329. https:\/\/doi.org\/10.1177\/0300060516675504. PubMed PMID: 28643578; PubMed Central PMCID: PMC5805190.","journal-title":"J Int Med Res diciembre de"},{"key":"2157_CR99","doi-asserted-by":"publisher","unstructured":"Gallinoro E, Paolisso P, Candreva A, Bermpeis K, Fabbricatore D, Esposito G et al. Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve. Front Cardiovasc Med. 19 de octubre de 2021;8. https:\/\/doi.org\/10.3389\/fcvm.2021.765071","DOI":"10.3389\/fcvm.2021.765071"},{"key":"2157_CR100","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-017-0652-1","volume":"17","author":"L Potier","year":"2018","unstructured":"Potier L, Chequer R, Roussel R, Mohammedi K, Sismail S, Hartemann A, et al. Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus. Cardiovasc Diabetol 11 de enero de. 2018;17:11. https:\/\/doi.org\/10.1186\/s12933-017-0652-1. PubMed PMID: 29325551; PubMed Central PMCID: PMC5763541.","journal-title":"Cardiovasc Diabetol 11 de enero de"},{"issue":"15","key":"2157_CR101","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","volume":"126","author":"VL Murthy","year":"2012","unstructured":"Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 9 de octubre de. 2012;126(15):1858\u201368. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.120402. PubMed PMID: 22919001; PubMed Central PMCID: PMC3495105.","journal-title":"Circulation 9 de octubre de"},{"key":"2157_CR102","unstructured":"WHO. WHO [Internet]. 2024 [citado 22 de noviembre de 2025]. The top 10 causes of death. Disponible en: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death"},{"key":"2157_CR103","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol. 22 de diciembre de 2020;76(25):2982\u20133021. doi:10.1016\/j.jacc.2020.11.010 PubMed PMID: 33309175; PubMed Central PMCID: PMC7755038."},{"issue":"9","key":"2157_CR104","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa1311890","volume":"371","author":"S Yusuf","year":"2014","unstructured":"Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, et al. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries. N Engl J Med 28 de agosto de. 2014;371(9):818\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1311890.","journal-title":"N Engl J Med 28 de agosto de"},{"issue":"1","key":"2157_CR105","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol 8 de junio de. 2018;17(1):83. https:\/\/doi.org\/10.1186\/s12933-018-0728-6. PubMed PMID: 29884191; PubMed Central PMCID: PMC5994068.","journal-title":"Cardiovasc Diabetol 8 de junio de"},{"key":"2157_CR106","doi-asserted-by":"publisher","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Eliasson B, Svensson AM, Miftaraj M et al. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. N Engl J Med 13 de abril de 2017;376(15):1407\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1608664 PubMed PMID: 28402770.","DOI":"10.1056\/NEJMoa1608664"},{"key":"2157_CR107","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12872-018-0993-z","volume":"19","author":"P Miranda-Machado","year":"2019","unstructured":"Miranda-Machado P, Salcedo-Mej\u00eda F, Wilches JP, Fernandez-Mercado J, De la Hoz-Restrepo F, Alvis-Guzm\u00e1n N. First cardiovascular event in patients with type 2 diabetes mellitus of a cardiovascular risk management program of a poor Colombian population: a cohort study. BMC Cardiovasc Disord 8 de enero de. 2019;19:8. https:\/\/doi.org\/10.1186\/s12872-018-0993-z. PubMed PMID: 30621603; PubMed Central PMCID: PMC6323759.","journal-title":"BMC Cardiovasc Disord 8 de enero de"},{"issue":"9493","key":"2157_CR108","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(","volume":"366","author":"JA Dormandy","year":"2005","unstructured":"Dormandy JA, Charbonnel B, Eckland DJA, Erdmann E, Massi-Benedetti M, Moules IK, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet Lond Engl 8 de octubre de. 2005;366(9493):1279\u201389. https:\/\/doi.org\/10.1016\/S0140-6736(. 05)67528-9 PubMed PMID: 16214598.","journal-title":"Lancet Lond Engl 8 de octubre de"},{"issue":"10193","key":"2157_CR109","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet Lond Engl 13 de julio de. 2019;394(10193):121\u201330. https:\/\/doi.org\/10.1016\/S0140-6736. (19)31149-3 PubMed PMID: 31189511.","journal-title":"Lancet Lond Engl 13 de julio de"},{"issue":"19","key":"2157_CR110","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 10 de noviembre de. 2016;375(19):1834\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1607141.","journal-title":"N Engl J Med 10 de noviembre de"},{"key":"2157_CR111","doi-asserted-by":"publisher","unstructured":"Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. World J Diabetes. 10 de julio de 2015;6(7):961\u20139. https:\/\/doi.org\/10.4239\/wjd.v6.i7.961 PubMed PMID: 26185603; PubMed Central PMCID: PMC4499529.","DOI":"10.4239\/wjd.v6.i7.961"},{"key":"2157_CR112","doi-asserted-by":"publisher","unstructured":"Soyoye DO, Abiodun OO, Ikem RT, Kolawole BA, Akintomide AO. Diabetes and peripheral artery disease: A review. World J Diabetes. 15 de junio de 2021;12(6):827\u201338. https:\/\/doi.org\/10.4239\/wjd.v12.i6.827 PubMed PMID: 34168731; PubMed Central PMCID: PMC8192257.","DOI":"10.4239\/wjd.v12.i6.827"},{"issue":"4","key":"2157_CR113","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/jcm14041383","volume":"14","author":"M Baty","year":"2025","unstructured":"Baty M, Chimoriya R, James S, Kritharides L, Behdasht S, Suryawanshi A, et al. Diabetes in Peripheral Artery Disease: Prevalence, Complications, and Polypharmacy. J Clin Med enero de. 2025;14(4):1383. https:\/\/doi.org\/10.3390\/jcm14041383.","journal-title":"J Clin Med enero de"},{"key":"2157_CR114","doi-asserted-by":"publisher","unstructured":"Gyldenkerne C, Olesen KKW, Kahlert J, Thrane PG, Hansen MK, Stoedkilde-Joergensen N et al. Twenty-year trends in peripheral artery disease, lower extremity revascularization, and lower extremity amputation in newly diagnosed type 2 diabetes. Eur Heart J. 28 de octubre de 2024;45(Supplement_1):ehae6662247. https:\/\/doi.org\/10.1093\/eurheartj\/ehae666.2247","DOI":"10.1093\/eurheartj\/ehae666.2247"},{"issue":"2","key":"2157_CR115","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/diabetology5020015","volume":"5","author":"AIP Ascencio","year":"2024","unstructured":"Ascencio AIP, Carmona EM, Far\u00edas JM, Medina DSG, Salas RG, Sauque Reyna L. Prevalence of Peripheral Arterial Disease and Principal Associated Risk Factors in Patients with Type 2 Diabetes Mellitus: The IDON-Peripheral Arterial Disease Study. Diabetol junio de. 2024;5(2):190\u2013205. https:\/\/doi.org\/10.3390\/diabetology5020015.","journal-title":"Diabetol junio de"},{"issue":"2","key":"2157_CR116","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.acmx.2017.02.002","volume":"88","author":"L Urbano","year":"2018","unstructured":"Urbano L, Portilla E, Mu\u00f1oz W, Hofman A, Sierra-Torres CH. Prevalence and risk factors associated with peripheral arterial disease in an adult population from Colombia. Arch Cardiol M\u00e9xico 1 de abril de. 2018;88(2):107\u201315. https:\/\/doi.org\/10.1016\/j.acmx.2017.02.002.","journal-title":"Arch Cardiol M\u00e9xico 1 de abril de"},{"issue":"10508","key":"2157_CR117","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736","volume":"406","author":"SS Khan","year":"2025","unstructured":"Khan SS, Berwanger O, Fiuzat M, McMurray JJ, Narula J, Prabhakaran D, et al. Prioritising the primary prevention of heart failure. Lancet Lond Engl 13 de septiembre de. 2025;406(10508):1138\u201353. https:\/\/doi.org\/10.1016\/S0140-6736. (25)01393-5 PubMed PMID: 40889513.","journal-title":"Lancet Lond Engl 13 de septiembre de"},{"key":"2157_CR118","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2025. Diabetes Care. 1 de enero de 2025;48(1 Suppl 1):S207-38. https:\/\/doi.org\/10.2337\/dc25-S010 PubMed PMID: 39651970; PubMed Central PMCID: PMC11635050.","DOI":"10.2337\/dc25-S010"},{"issue":"4","key":"2157_CR119","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00125-023-06068-2","volume":"67","author":"AG Hoek","year":"2024","unstructured":"Hoek AG, Dal Canto E, Wenker E, Bindraban N, Handoko ML, Elders PJM, et al. Epidemiology of heart failure in diabetes: a disease in disguise. Diabetologia abril de. 2024;67(4):574\u2013601. https:\/\/doi.org\/10.1007\/s00125-023-06068-2. PubMed PMID: 38334818; PubMed Central PMCID: PMC10904471.","journal-title":"Diabetologia abril de"},{"key":"2157_CR120","doi-asserted-by":"publisher","unstructured":"Ostrominski JW, Cheng AYY, Nelson AJ, Neuen BL, Sattar N, Tuttle KR et al. Cardiovascular, kidney, and metabolic health: an actionable vision for heart failure prevention. Lancet. 13 de septiembre de 2025;406(10508):1171\u201392. https:\/\/doi.org\/10.1016\/S0140-6736(25)01384-4 PubMed PMID: 40889511.","DOI":"10.1016\/S0140-6736"},{"key":"2157_CR121","doi-asserted-by":"publisher","unstructured":"Khan SS, Breathett K, Braun LT, Chow SL, Gupta DK, Lekavich C et al. Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 20 de mayo de 2025;151(20):e1006\u201326. https:\/\/doi.org\/10.1161\/CIR.0000000000001307","DOI":"10.1161\/CIR.0000000000001307"},{"issue":"10166","key":"2157_CR122","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Lond Engl 5 de enero de. 2019;393(10166):31\u20139. https:\/\/doi.org\/10.1016\/S0140. -6736(18)32590-X PubMed PMID: 30424892.","journal-title":"Lancet Lond Engl 5 de enero de"},{"key":"2157_CR123","doi-asserted-by":"publisher","unstructured":"Pratley RE, Tuttle KR, Rossing P, Rasmussen S, Perkovic V, Nielsen OW et al. Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial. J Am Coll Cardiol. 22 de octubre de 2024;84(17):1615\u201328. https:\/\/doi.org\/10.1016\/j.jacc.2024.08.004 PubMed PMID: 39217553.","DOI":"10.1016\/j.jacc.2024.08"},{"key":"2157_CR124","doi-asserted-by":"publisher","unstructured":"Filippatos G, Anker SD, Agarwal R, Ruilope LM, Rossing P, Bakris GL et al. Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial. Circulation. 8 de febrero de 2022;145(6):437\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057983 PubMed PMID: 34775784; PubMed Central PMCID: PMC8812430.","DOI":"10.1161\/CIRCULATIONAHA.121.057983"},{"key":"2157_CR125","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1475-2840-11-147","volume":"11","author":"CT Zhao","year":"2012","unstructured":"Zhao CT, Wang M, Siu CW, Hou YL, Wang T, Tse HF, et al. Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress. Cardiovasc Diabetol 5 de diciembre de. 2012;11:147. https:\/\/doi.org\/10.1186\/1475-2840-11-147. PubMed PMID: 23217199; PubMed Central PMCID: PMC3537556.","journal-title":"Cardiovasc Diabetol 5 de diciembre de"},{"issue":"13","key":"2157_CR126","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.3390\/jcm10132924","volume":"10","author":"D Acanfora","year":"2021","unstructured":"Acanfora D, Ciccone MM, Carlomagno V, Scicchitano P, Acanfora C, Bortone AS, et al. A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index. J Clin Med 29 de junio de. 2021;10(13):2924. https:\/\/doi.org\/10.3390\/jcm10132924. PubMed PMID: 34210028; PubMed Central PMCID: PMC8268134.","journal-title":"J Clin Med 29 de junio de"},{"issue":"10104","key":"2157_CR127","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S0140-6736","volume":"390","author":"D Vinereanu","year":"2017","unstructured":"Vinereanu D, Lopes RD, Bahit MC, Xavier D, Jiang J, Al-Khalidi HR, et al. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet Lond Engl 14 de octubre de. 2017;390(10104):1737\u201346. https:\/\/doi.org\/10.1016\/S0140-6736. (17)32165-7 PubMed PMID: 28859942.","journal-title":"Lancet Lond Engl 14 de octubre de"},{"key":"2157_CR128","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ahj.2023.06.007","volume":"264","author":"RD Lopes","year":"2023","unstructured":"Lopes RD, de Barros E, Silva PGM, Filho CRH, Cavalvante MA, Miranda CM, Esper RB, et al. The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study. Am Heart J octubre de. 2023;264:97\u2013105. https:\/\/doi.org\/10.1016\/j.ahj.2023.06.007. PubMed PMID: 37330162.","journal-title":"Am Heart J octubre de"},{"key":"2157_CR129","doi-asserted-by":"publisher","first-page":"109147","DOI":"10.1016\/j.diabres.2021.109147","volume":"182","author":"S Drogkaris","year":"2021","unstructured":"Drogkaris S, Thomopoulos C, Kalos T, Manta E, Tsioufis C. Net clinical benefit of direct oral anticoagulants in atrial fibrillation patients with or without diabetes mellitus: A meta-analysis of outcome trials. Diabetes Res Clin Pract diciembre de. 2021;182:109147. https:\/\/doi.org\/10.1016\/j.diabres.2021.109147. PubMed PMID: 34793880.","journal-title":"Diabetes Res Clin Pract diciembre de"},{"issue":"1","key":"2157_CR130","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","volume":"83","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation. JACC 2 de enero de. 2024;83(1):109\u2013279. https:\/\/doi.org\/10.1016\/j.jacc.2023.08.017.","journal-title":"JACC 2 de enero de"},{"issue":"36","key":"2157_CR131","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 29 de septiembre de. 2024;45(36):3314\u2013414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176. PubMed PMID: 39210723.","journal-title":"Eur Heart J 29 de septiembre de"},{"key":"2157_CR132","doi-asserted-by":"publisher","unstructured":"Lim J, Kwak S, Choi Y, Rhee T, Park CS, Kim B et al. Differing Efficacy of Dapagliflozin Versus Empagliflozin on the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes: A Real-World Observation Using a Nationwide, Population\u2010Based Cohort. J Am Heart Assoc. 6 de febrero de. 2024;13(3):e030552. https:\/\/doi.org\/10.1161\/JAHA.123.030552","DOI":"10.1161\/JAHA.123.030552"},{"key":"2157_CR133","doi-asserted-by":"publisher","unstructured":"Zelniker TA, Bonaca MP, Furtado RHM, Mosenzon O, Kuder JF, Murphy SA et al. Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus. Circulation. 14 de abril de 2020;141(15):1227\u201334. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044183","DOI":"10.1161\/CIRCULATIONAHA.119.044183"},{"issue":"5","key":"2157_CR134","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1161\/STROKEAHA.116.015756","volume":"48","author":"B Zinman","year":"2017","unstructured":"Zinman B, Inzucchi SE, Lachin JM, Wanner C, Fitchett D, Kohler S, et al. Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk. Stroke mayo de. 2017;48(5):1218\u201325. https:\/\/doi.org\/10.1161\/STROKEAHA.116.015756. PubMed PMID: 28386035; PubMed Central PMCID: PMC5404404.","journal-title":"Stroke mayo de"},{"issue":"3","key":"2157_CR135","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4103\/ijem","volume":"22","author":"M Dharmalingam","year":"2018","unstructured":"Dharmalingam M, Yamasandhi PG. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Indian J Endocrinol Metab. 2018;22(3):421\u20138. https:\/\/doi.org\/10.4103\/ijem. .IJEM_585_17 PubMed PMID: 30090738; PubMed Central PMCID: PMC6063173.","journal-title":"Indian J Endocrinol Metab"},{"key":"2157_CR136","doi-asserted-by":"publisher","first-page":"d3897","DOI":"10.1136\/bmj.d","volume":"343","author":"QM Anstee","year":"2011","unstructured":"Anstee QM, McPherson S, Day CP. How big a problem is non-alcoholic fatty liver disease? BMJ. 18 de julio de. 2011;343:d3897. https:\/\/doi.org\/10.1136\/bmj.d. 3897 PubMed PMID: 21768191.","journal-title":"18 de julio de"},{"issue":"7","key":"2157_CR137","doi-asserted-by":"publisher","first-page":"e0303564","DOI":"10.1371\/journal.pone.0303564","volume":"19","author":"U Abbas","year":"2024","unstructured":"Abbas U, Shah SA, Babar N, Agha P, Khowaja MA, Nasrumminallah M, et al. Cardiorespiratory dynamics of type 2 diabetes mellitus: An extensive view of breathing and fitness challenges in a diabetes prevalent population. PLOS ONE 5 de julio de. 2024;19(7):e0303564. https:\/\/doi.org\/10.1371\/journal.pone.0303564. PubMed PMID: 38968192; PubMed Central PMCID: PMC11226084.","journal-title":"PLOS ONE 5 de julio de"},{"key":"2157_CR138","doi-asserted-by":"publisher","first-page":"100395","DOI":"10.1016\/j.ahjo.2024.100395","volume":"42","author":"GA Ung","year":"2024","unstructured":"Ung GA, Nguyen KH, Hui A, Wong ND, Dineen EH. Impact of cardiorespiratory fitness and diabetes status on cardiovascular disease and all-cause mortality: An NHANES retrospective cohort study. Am Heart J Plus Cardiol Res Pract 17 de abril de. 2024;42:100395. https:\/\/doi.org\/10.1016\/j.ahjo.2024.100395. PubMed PMID: 38689681; PubMed Central PMCID: PMC11059329.","journal-title":"Am Heart J Plus Cardiol Res Pract 17 de abril de"},{"key":"2157_CR139","doi-asserted-by":"publisher","unstructured":"Wang Y, Lee DC, Brellenthin AG, Sui X, Church TS, Lavie CJ et al. Association of Muscular Strength and Incidence of Type 2 Diabetes. Mayo Clin Proc. abril de. 2019;94(4):643\u2009\u2013\u200951. https:\/\/doi.org\/10.1016\/j.mayocp.2018.08.037 PubMed PMID: 30871784; PubMed Central PMCID: PMC6450733.","DOI":"10.1016\/j.mayocp.2018.08.037"},{"issue":"5","key":"2157_CR140","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11154-025-09947-8","volume":"26","author":"AA Al-Awadi","year":"2025","unstructured":"Al-Awadi AA, Gray SR, Al-Ozairi E. Are strategies to increase muscle mass and strength as effective in people with type 2 diabetes? Rev Endocr Metab Disord. 2025;26(5):857\u201370. https:\/\/doi.org\/10.1007\/s11154-025-09947-8. PubMed PMID: 39998784; PubMed Central PMCID: PMC12534332.","journal-title":"Rev Endocr Metab Disord"},{"key":"2157_CR141","unstructured":"American Diabetes Association. American Diabetes Association [Internet]. 2025 [citado 30 de septiembre de 2025]. Key Medical Screenings for Diabetes: A1C, Statins, and More. Disponible en: https:\/\/diabetes.org\/living-with-diabetes\/newly-diagnosed\/health-checks-people-with-diabetes"},{"issue":"9","key":"2157_CR142","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.aprim.2020.03.005","volume":"52","author":"FJ F\u00e9lix-Redondo","year":"2020","unstructured":"F\u00e9lix-Redondo FJ, Subirana I, Baena-Diez JM, Ramos R, Cancho B, Fern\u00e1ndez-Berg\u00e9s D, et al. Importancia pron\u00f3stica de la enfermedad arterial perif\u00e9rica diagnosticada mediante el \u00edndice tobillo-brazo en poblaci\u00f3n general espa\u00f1ola. Aten Primaria noviembre de. 2020;52(9):627\u201336. https:\/\/doi.org\/10.1016\/j.aprim.2020.03.005. PubMed PMID: 32505482; PubMed Central PMCID: PMC7713094.","journal-title":"Aten Primaria noviembre de"},{"key":"2157_CR143","doi-asserted-by":"publisher","unstructured":"Tehan PE, Mills J, Leask S, Oldmeadow C, Peterson B, Sebastian M et al. Toe-brachial index and toe systolic blood pressure for the diagnosis of peripheral arterial disease - Tehan, PE\u2009\u2013\u20092024 | Cochrane Library [Internet]. [citado 27 de octubre de 2025]. Disponible en: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/https:\/\/doi.org\/10.1002\/14651858.CD013783.pub2\/full","DOI":"10.1002\/14651858.CD013783.pub2\/full"},{"issue":"2","key":"2157_CR144","doi-asserted-by":"publisher","first-page":"107810","DOI":"10.1016\/j.jdiacomp.2020.107810","volume":"35","author":"PP Harms","year":"2021","unstructured":"Harms PP, van der Heijden AA, Rutters F, Tan HL, Beulens JWJ, Nijpels G, et al. Prevalence of ECG abnormalities in people with type 2 diabetes: The Hoorn Diabetes Care System cohort. J Diabetes Complications 1 de febrero de. 2021;35(2):107810. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107810.","journal-title":"J Diabetes Complications 1 de febrero de"},{"issue":"1","key":"2157_CR145","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/14017431.2022.2095435","volume":"56","author":"MCT Gregers","year":"2022","unstructured":"Gregers MCT, Schou M, Jensen MT, Jensen J, Petrie MC, Vilsb\u00f8ll T, et al. Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes. Scand Cardiovasc J 31 de diciembre de. 2022;56(1):256\u201363. https:\/\/doi.org\/10.1080\/14017431.2022.2095435. PubMed PMID: 35811473.","journal-title":"Scand Cardiovasc J 31 de diciembre de"},{"key":"2157_CR146","first-page":"105","volume":"24","author":"D Quesada Chaves","year":"2022","unstructured":"Quesada Chaves D, Coto Yglesias F, Gonz\u00e1lez Volio M, Herrera Mart\u00ednez D, Herrera Peraza HK, Jim\u00e9nez Montero JG, et al. M\u00d3DULO 5 Medidas no farmacol\u00f3gicas. Rev Costarric Cardiol julio de. 2022;24:105\u201316.","journal-title":"Rev Costarric Cardiol julio de"},{"issue":"9","key":"2157_CR147","doi-asserted-by":"publisher","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","volume":"145","author":"JJ Joseph","year":"2022","unstructured":"Joseph JJ, Deedwania P, Acharya T, Aguilar D, Bhatt DL, Chyun DA, et al. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association. Circulation marzo de. 2022;145(9):e722\u201359. https:\/\/doi.org\/10.1161\/CIR.0000000000001040.","journal-title":"Circulation marzo de"},{"key":"2157_CR148","doi-asserted-by":"publisher","unstructured":"Barrea L, Vetrani C, Verde L, Frias-Toral E, Ceriani F, Cernea S et al. Comprehensive Approach to Medical Nutrition Therapy in Patients with Type 2 Diabetes Mellitus: From Diet to Bioactive Compounds. Antioxidants. 10 de abril de 2023;12(4):904. https:\/\/doi.org\/10.3390\/antiox12040904 PubMed PMID: 37107279; PubMed Central PMCID: PMC10135374.","DOI":"10.3390\/antiox12040904"},{"key":"2157_CR149","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes\u20142024. Diabetes Care. 11 de diciembre de 2023;47(Suppl 1):S77-110. https:\/\/doi.org\/10.2337\/dc24-S005 PubMed PMID: 38078584; PubMed Central PMCID: PMC10725816.","DOI":"10.2337\/dc24-S005"},{"issue":"28","key":"2157_CR150","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1093\/eurheartj\/ehad269","volume":"44","author":"A Mente","year":"2023","unstructured":"Mente A, Dehghan M, Rangarajan S, O\u2019Donnell M, Hu W, Dagenais G, et al. Diet, cardiovascular disease, and mortality in 80 countries. Eur Heart J 21 de julio de. 2023;44(28):2560\u201379. https:\/\/doi.org\/10.1093\/eurheartj\/ehad269. PubMed PMID: 37414411; PubMed Central PMCID: PMC10361015.","journal-title":"Eur Heart J 21 de julio de"},{"issue":"2","key":"2157_CR151","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MED.0000000000000589","volume":"28","author":"PJ Nestel","year":"2021","unstructured":"Nestel PJ, Sullivan DR, Mori TA. Dietary management of cardiovascular risk including type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 1 de abril de. 2021;28(2):134\u201341. 10. 1097\/MED.0000000000000589 PubMed PMID: 33186195.","journal-title":"Curr Opin Endocrinol Diabetes Obes 1 de abril de"},{"key":"2157_CR152","unstructured":"Reynolds A, Mitri J. Dietary Advice For Individuals with Diabetes. En: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, editores. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000 [citado 1 de octubre de 2025]. Disponible en: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279012\/ PubMed PMID: 25905243."},{"issue":"9","key":"2157_CR153","doi-asserted-by":"publisher","first-page":"102947","DOI":"10.1016\/j.aprim.2024.102947","volume":"56","author":"MA Botana L\u00f3pez","year":"2024","unstructured":"Botana L\u00f3pez MA. Estrategias para la prevenci\u00f3n y tratamiento no farmacol\u00f3gico de la diabetes. Modelos de atenci\u00f3n. Aten Primaria septiembre de. 2024;56(9):102947. https:\/\/doi.org\/10.1016\/j.aprim.2024.102947. PubMed PMID: 38678855; PubMed Central PMCID: PMC11066989.","journal-title":"Aten Primaria septiembre de"},{"issue":"1","key":"2157_CR154","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1017\/S0007114511005381","volume":"108","author":"TP de Paula","year":"2012","unstructured":"de Paula TP, Steemburgo T, de Almeida JC, Dall\u2019Alba V, Gross JL, de Azevedo MJ. The role of Dietary Approaches to Stop Hypertension (DASH) diet food groups in blood pressure in type 2 diabetes. Br J Nutr 14 de julio de. 2012;108(1):155\u201362. doi:10.1017\/S0007114511005381 PubMed PMID: 22142820.","journal-title":"Br J Nutr 14 de julio de"},{"issue":"2","key":"2157_CR155","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2337\/diacare.27","volume":"27","author":"JD Ard","year":"2004","unstructured":"Ard JD, Grambow SC, Liu D, Slentz CA, Kraus WE, Svetkey LP, et al. The effect of the PREMIER interventions on insulin sensitivity. Diabetes Care febrero de. 2004;27(2):340\u20137. https:\/\/doi.org\/10.2337\/diacare.27. .2.340 PubMed PMID: 14747211.","journal-title":"Diabetes Care febrero de"},{"issue":"10","key":"2157_CR156","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1038\/s41591-025-03823-3","volume":"31","author":"M Fang","year":"2025","unstructured":"Fang M, Wang D, Rebholz CM, Echouffo-Tcheugui JB, Tang O, Wang NY, et al. DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial. Nat Med octubre de. 2025;31(10):3309\u201316. https:\/\/doi.org\/10.1038\/s41591-025-03823-3.","journal-title":"Nat Med octubre de"},{"issue":"3","key":"2157_CR157","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3945\/ajcn.112.042457","volume":"97","author":"O Ajala","year":"2013","unstructured":"Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr marzo de. 2013;97(3):505\u201316. https:\/\/doi.org\/10.3945\/ajcn.112.042457. PubMed PMID: 23364002.","journal-title":"Am J Clin Nutr marzo de"},{"issue":"11","key":"2157_CR158","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/ejcn.2014.243","volume":"69","author":"R Huo","year":"2015","unstructured":"Huo R, Du T, Xu Y, Xu W, Chen X, Sun K, et al. Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis. Eur J Clin Nutr noviembre de. 2015;69(11):1200\u20138. https:\/\/doi.org\/10.1038\/ejcn.2014.243. PubMed PMID: 25369829.","journal-title":"Eur J Clin Nutr noviembre de"},{"issue":"7","key":"2157_CR159","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.metabol.2014.04.010","volume":"63","author":"E Koloverou","year":"2014","unstructured":"Koloverou E, Esposito K, Giugliano D, Panagiotakos D. The effect of Mediterranean diet on the development of type 2 diabetes mellitus: a meta-analysis of 10 prospective studies and 136,846 participants. Metabolism julio de. 2014;63(7):903\u201311. https:\/\/doi.org\/10.1016\/j.metabol.2014.04.010. PubMed PMID: 24931280.","journal-title":"Metabolism julio de"},{"issue":"5","key":"2157_CR160","doi-asserted-by":"publisher","first-page":"103044","DOI":"10.1016\/j.dsx.2024.103044","volume":"18","author":"M Walicka","year":"2024","unstructured":"Walicka M, Krysi\u0144ski A, La Rosa GRM, Sun A, Campagna D, Di Ciaula A, et al. Influence of quitting smoking on diabetes-related complications: A scoping review with a systematic search strategy. Diabetes Metab Syndr mayo de. 2024;18(5):103044. https:\/\/doi.org\/10.1016\/j.dsx.2024.103044. PubMed PMID: 38810420.","journal-title":"Diabetes Metab Syndr mayo de"},{"key":"2157_CR161","doi-asserted-by":"publisher","unstructured":"Ohkuma T, Iwase M, Fujii H, Kaizu S, Ide H, Jodai T et al. Dose- and Time-Dependent Association of Smoking and Its Cessation with Glycemic Control and Insulin Resistance in Male Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry. PLoS ONE. 30 de marzo de 2015;10(3):e0122023. https:\/\/doi.org\/10.1371\/journal.pone.0122023 PubMed PMID: 25822499; PubMed Central PMCID: PMC4379103.","DOI":"10.1371\/journal.pone.0122023"},{"issue":"39","key":"2157_CR162","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J 14 de octubre de. 2023;44(39):4043\u2013140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad. 192 PubMed PMID: 37622663.","journal-title":"Eur Heart J 14 de octubre de"},{"issue":"1","key":"2157_CR163","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14283\/jfa.2017.39","volume":"7","author":"AJ Sinclair","year":"2018","unstructured":"Sinclair AJ, Abdelhafiz A, Dunning T, Izquierdo M, Rodriguez Manas L, Bourdel-Marchasson I, et al. An International Position Statement on the Management of Frailty in Diabetes Mellitus: Summary of Recommendations 2017. J Frailty Aging. 2018;7(1):10\u201320. https:\/\/doi.org\/10.14283\/jfa.2017.39. PubMed PMID: 29412437.","journal-title":"J Frailty Aging"},{"key":"2157_CR164","doi-asserted-by":"publisher","unstructured":"Bi Y, Li M, Liu Y, Li T, Lu J, Duan P et al. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes. N Engl J Med. 26 de marzo de 2025;392(12):1155\u201367. https:\/\/doi.org\/10.1056\/NEJMoa2412006","DOI":"10.1056\/NEJMoa2412006"},{"issue":"17","key":"2157_CR165","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","volume":"362","author":"The ACCORD Study Group","year":"2010","unstructured":"The ACCORD Study Group. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med 29 de abril de. 2010;362(17):1575\u201385. https:\/\/doi.org\/10.1056\/NEJMoa1001286.","journal-title":"N Engl J Med 29 de abril de"},{"issue":"9721","key":"2157_CR166","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(","volume":"375","author":"GL Bakris","year":"2010","unstructured":"Bakris GL, Sarafidis PA, Weir MR, Dahl\u00f6f B, Pitt B, Jamerson K, et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 3 de abril de. 2010;375(9721):1173\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(. 09)62100-0 PubMed PMID: 20170948.","journal-title":"Lancet 3 de abril de"},{"issue":"9","key":"2157_CR167","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s00125-017-4336-x","volume":"60","author":"E Sanchez-Rangel","year":"2017","unstructured":"Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia septiembre de. 2017;60(9):1586\u201393. https:\/\/doi.org\/10.1007\/s00125-017-4336-x. PubMed PMID: 28770321.","journal-title":"Diabetologia septiembre de"},{"issue":"1","key":"2157_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13300-020-00961-4","volume":"12","author":"R Mehta","year":"2021","unstructured":"Mehta R, Pichel D, Chen-Ku CH, Raffaele P, M\u00e9ndez Dur\u00e1n A, Padilla F, et al. Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic\u2013Cardio\u2013Renal Perspective for the Primary Care Physician. Diabetes Ther enero de. 2021;12(1):1\u201320. https:\/\/doi.org\/10.1007\/s13300-020-00961-4. PubMed PMID: 33325006; PubMed Central PMCID: PMC7843679.","journal-title":"Diabetes Ther enero de"},{"issue":"13","key":"2157_CR169","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMcp2000280","volume":"384","author":"RR Kalyani","year":"2021","unstructured":"Kalyani RR. Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes. N Engl J Med 1 de abril de. 2021;384(13):1248\u201360. 10.1056. \/NEJMcp2000280 PubMed PMID: 33789013.","journal-title":"N Engl J Med 1 de abril de"},{"key":"2157_CR170","doi-asserted-by":"publisher","first-page":"154295","DOI":"10.1016\/j.metabol.2020.154295","volume":"109","author":"AP Stoian","year":"2020","unstructured":"Stoian AP, Sachinidis A, Stoica RA, Nikolic D, Patti AM, Rizvi AA. The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes. Metabolism agosto de. 2020;109:154295. https:\/\/doi.org\/10.1016\/j.metabol.2020.154295. PubMed PMID: 32553739.","journal-title":"Metabolism agosto de"},{"issue":"6","key":"2157_CR171","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1111\/dom.16335","volume":"27","author":"C Witt","year":"2025","unstructured":"Witt C, Renfroe LG, Lyons TS. Discordance between serum cholesterol concentration and atherogenic lipoprotein particle number in people with metabolic disease: A systematic review. Diabetes Obes Metab junio de. 2025;27(6):2940\u201354. https:\/\/doi.org\/10.1111\/dom.16335. PubMed PMID: 40091449.","journal-title":"Diabetes Obes Metab junio de"},{"issue":"1","key":"2157_CR172","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S2213-8587","volume":"12","author":"KK Ray","year":"2024","unstructured":"Ray KK, Nicholls SJ, Li N, Louie MJ, Brennan D, Lincoff AM, et al. Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial. Lancet Diabetes Endocrinol enero de. 2024;12(1):19\u201328. https:\/\/doi.org\/10.1016\/S2213-8587. (23)00316-9 PubMed PMID: 38061370.","journal-title":"Lancet Diabetes Endocrinol enero de"},{"key":"2157_CR173","doi-asserted-by":"publisher","unstructured":"Bohula EA, Marston NA, Bhatia AK, Ferrari GMD, Leiter LA, Nicolau JC et al. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke. N Engl J Med. 8 de noviembre de 2025. Located at: world. https:\/\/doi.org\/10.1056\/NEJMoa2514428","DOI":"10.1056\/NEJMoa2514428"},{"issue":"1","key":"2157_CR174","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11886-025-02317-5","volume":"28","author":"M Nejabat","year":"2026","unstructured":"Nejabat M, Katsiki N, Mukherjee D, Hadizadeh F, Sahebkar A. Cholesteryl Ester Transfer Protein Inhibitors: State of the Science. Curr Cardiol Rep 6 de enero de. 2026;28(1):10. https:\/\/doi.org\/10.1007\/s11886-025-02317-5.","journal-title":"Curr Cardiol Rep 6 de enero de"},{"issue":"1","key":"2157_CR175","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2337\/dc18-1491","volume":"42","author":"LA Leiter","year":"2019","unstructured":"Leiter LA, Teoh H, Kallend D, Wright RS, Landmesser U, Wijngaard PLJ, et al. Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial. Diabetes Care enero de. 2019;42(1):173\u20136. https:\/\/doi.org\/10.2337\/dc18-1491. PubMed PMID: 30487231.","journal-title":"Diabetes Care enero de"},{"key":"2157_CR176","doi-asserted-by":"publisher","unstructured":"Schmidt AF, Carter JPL, Pearce LS, Wilkins JT, Overington JP, Hingorani AD et al. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 20 de octubre de 2020;10(10):CD011748. https:\/\/doi.org\/10.1002\/14651858.CD011748.pub3 PubMed PMID: 33078867; PubMed Central PMCID: PMC8094613.","DOI":"10.1002\/14651858.CD011748.pub3"},{"key":"2157_CR177","doi-asserted-by":"publisher","unstructured":"Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 3 de enero de. 2019;380(1):11\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1812792","DOI":"10.1056\/NEJMoa1812792"},{"issue":"2","key":"2157_CR178","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12020-023-03401","volume":"81","author":"R Rodriguez-Gutierrez","year":"2023","unstructured":"Rodriguez-Gutierrez R, Garcia-Leal M, Raygoza-Cortez K, Flores-Rodr\u00edguez A, Moreno-Alvarado M, Heredia-Mart\u00ednez EM, et al. Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis. Endocr agosto de. 2023;81(2):231\u201345. https:\/\/doi.org\/10.1007\/s12020-023-03401. -y PubMed PMID: 37247046.","journal-title":"Endocr agosto de"},{"key":"2157_CR179","doi-asserted-by":"publisher","unstructured":"The ASCEND Study Collaborative Group. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. N Engl J Med. 17 de octubre de 2018;379(16):1529\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1804988","DOI":"10.1056\/NEJMoa1804988"},{"key":"2157_CR180","doi-asserted-by":"publisher","unstructured":"Woolcott OO. The Latin American Diabetes Association 2025 congress. Lancet Reg Health \u2013 Am. 1 de febrero de 2026;54. https:\/\/doi.org\/10.1016\/j.lana.2026.101378","DOI":"10.1016\/j.lana.2026.101378"},{"key":"2157_CR181","unstructured":"Ken Research. Latin America SGLT2 Inhibitor Market | 2019\u20132030 | Ken Research [Internet]. 2024 [citado 2 de marzo de 2026]. Disponible en: https:\/\/www.kenresearch.com\/latin-america-sodium-glucose-cotransport-2-sglt2-inhibitor-market"},{"issue":"3","key":"2157_CR182","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/dom.13955","volume":"22","author":"M Husain","year":"2020","unstructured":"Husain M, Bain SC, Jeppesen OK, Lingvay I, S\u00f8rrig R, Treppendahl MB, et al. Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk. Diabetes Obes Metab marzo de. 2020;22(3):442\u201351. https:\/\/doi.org\/10.1111\/dom.13955. PubMed PMID: 31903692; PubMed Central PMCID: PMC7064975.","journal-title":"Diabetes Obes Metab marzo de"},{"key":"2157_CR183","unstructured":"Mordor Intelligence. Mordor Intelligence [Internet]. 2026 [citado 2 de marzo de 2026]. Latin America Glucagon-like Peptide-1 Agonists Market - GLP-1 - Size, Share & Analysis. Disponible en: https:\/\/www.mordorintelligence.com\/industry-reports\/latin-america-glucagon-like-peptide-1-agonists-market"},{"key":"2157_CR184","doi-asserted-by":"publisher","first-page":"117313","DOI":"10.1016\/j.atherosclerosis","volume":"394","author":"A Chait","year":"2024","unstructured":"Chait A, Eckel RH, Vrablik M, Zambon A. Lipid-lowering in diabetes: An update. Atherosclerosis julio de. 2024;394:117313. https:\/\/doi.org\/10.1016\/j.atherosclerosis. .2023.117313 PubMed PMID: 37945448.","journal-title":"Atherosclerosis julio de"},{"issue":"8","key":"2157_CR185","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1177\/17474930241253988","volume":"19","author":"A Adamou","year":"2024","unstructured":"Adamou A, Barkas F, Milionis H, Ntaios G. Glucagon-like peptide-1 receptor agonists and stroke: A systematic review and meta-analysis of cardiovascular outcome trials. Int J Stroke Off J Int Stroke Soc octubre de. 2024;19(8):876\u201387. doi:10.1177\/17474930241253988 PubMed PMID: 38676552.","journal-title":"Int J Stroke Off J Int Stroke Soc octubre de"},{"issue":"10489","key":"2157_CR186","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/S0140-6736(","volume":"405","author":"MP Bonaca","year":"2025","unstructured":"Bonaca MP, Catarig AM, Houlind K, Ludvik B, Nordanstig J, Ramesh CK, et al. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial. Lancet Lond Engl 3 de mayo de. 2025;405(10489):1580\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(. 25)00509-4 PubMed PMID: 40169145.","journal-title":"Lancet Lond Engl 3 de mayo de"},{"issue":"1","key":"2157_CR187","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1358863X221143811","volume":"28","author":"N Skeik","year":"2023","unstructured":"Skeik N, Elejla SA, Sethi A, Manunga J, Mirza A. Effects of SGLT2 inhibitors and GLP1-receptor agonists on cardiovascular and limb events in peripheral artery disease: A review. Vasc Med Lond Engl febrero de. 2023;28(1):62\u201376. https:\/\/doi.org\/10.1177\/1358863X221143811. PubMed PMID: 36593757.","journal-title":"Vasc Med Lond Engl febrero de"},{"issue":"6","key":"2157_CR188","doi-asserted-by":"publisher","first-page":"851","DOI":"10.7326\/M21-4284","volume":"175","author":"X Zou","year":"2022","unstructured":"Zou X, Shi Q, Vandvik PO, Guyatt G, Lang CC, Parpia S, et al. Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure : A Systematic Review and Meta-analysis. Ann Intern Med junio de. 2022;175(6):851\u201361. doi:10.7326\/M21-4284 PubMed PMID: 35404670.","journal-title":"Ann Intern Med junio de"},{"issue":"10456","key":"2157_CR189","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736","volume":"404","author":"MN Kosiborod","year":"2024","unstructured":"Kosiborod MN, Deanfield J, Pratley R, Borlaug BA, Butler J, Davies MJ, et al. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials. Lancet Lond Engl 7 de septiembre de. 2024;404(10456):949\u201361. https:\/\/doi.org\/10.1016\/S0140-6736. (24)01643-X PubMed PMID: 39222642.","journal-title":"Lancet Lond Engl 7 de septiembre de"},{"key":"2157_CR190","doi-asserted-by":"publisher","unstructured":"Packer M, Zile MR, Kramer CM, DiMaria JM, Baum SJ, Litwin SE et al. Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification-Based Analysis. J Am Coll Cardiol. 9 de septiembre de 2025;86(10):696\u2013707. https:\/\/doi.org\/10.1016\/j.jacc.2025.06.058 PubMed PMID: 40903131.","DOI":"10.1016\/j.jacc.2025.06.058"},{"key":"2157_CR191","doi-asserted-by":"publisher","unstructured":"Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS et al. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 24 de octubre de 2024;391(16):1475\u201385. https:\/\/doi.org\/10.1056\/NEJMoa2407107 PubMed PMID: 39225278.","DOI":"10.1056\/NEJMoa2407107"},{"key":"2157_CR192","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2025. Diabetes Care. 1 de enero de 2025;48(1 Suppl 1):S239-51. https:\/\/doi.org\/10.2337\/dc25-S011 PubMed PMID: 39651975; PubMed Central PMCID: PMC11635029.","DOI":"10.2337\/dc25-S011"},{"key":"2157_CR193","doi-asserted-by":"publisher","unstructured":"Kramer H, Lerma EV, Koncicki H. editores. Kidney Disease in the Elderly: A Case-Based Guide [Internet]. Cham: Springer Nature Switzerland; 2024 [citado 2 de noviembre de 2025]. Disponible en: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-3-031-68460-9 doi:10.1007\/978-3-031-68460-9.","DOI":"10.1007\/978-3-031-68460-9"},{"issue":"9","key":"2157_CR194","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/ph18091337","volume":"18","author":"E Pirera","year":"2025","unstructured":"Pirera E, Di Raimondo D, D\u2019Anna L, Tuttolomondo A. Efficacy of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Moderate-to-Severe COPD Exacerbations Among Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Pharmaceuticals septiembre de. 2025;18(9):1337. https:\/\/doi.org\/10.3390\/ph18091337.","journal-title":"Pharmaceuticals septiembre de"},{"issue":"18","key":"2157_CR195","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.3390\/jcm14186355","volume":"14","author":"GE Diaz","year":"2025","unstructured":"Diaz GE, Mostacero GH, Huaman\u00ed B, Gutierrez-Rodriguez R, Rivera-Lozada O, Yangali-Vicente J, et al. Finerenone Versus Placebo on Renal Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review and Meta-Analysis. J Clin Med enero de. 2025;14(18):6355. https:\/\/doi.org\/10.3390\/jcm14186355.","journal-title":"J Clin Med enero de"},{"issue":"2","key":"2157_CR196","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med 10 de julio de. 2024;391(2):109\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2403347.","journal-title":"N Engl J Med 10 de julio de"},{"key":"2157_CR197","doi-asserted-by":"publisher","unstructured":"de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM et al. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 1 de diciembre de 2022;45(12):3075\u201390. https:\/\/doi.org\/10.2337\/dci22-0027 PubMed PMID: 36189689; PubMed Central PMCID: PMC9870667.","DOI":"10.2337\/dci22-0027"},{"key":"2157_CR198","doi-asserted-by":"publisher","unstructured":"Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl AK et al. Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. N Engl J Med. 6 de agosto de 2025;393(6):533\u201343. https:\/\/doi.org\/10.1056\/NEJMoa2410659","DOI":"10.1056\/NEJMoa2410659"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02157-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02157-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02157-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:52:47Z","timestamp":1779843167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02157-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":198,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2157"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02157-5","relation":{"references":[{"id-type":"doi","id":"10.4093\/dmj.2021.0258","asserted-by":"subject"}]},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This consensus used secondary, publicly available information. No patient data was used directly from the authors. The ethical board of Universidad de las Americas granted a excision letter under the project 516.B.XV.24.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}